Pure Global
NCT04845308

Radiographic Evaluation of Secondary Alveolar Bone Grafting in Patients With Alveolar Cleft

3D Radiographic Evaluation of the Long Terms Results of Secondary Alveolar Bone Grafting in Patients With Alveolar Cleft: Comparison of Early Versus Late Secondary Grafting SABG : Secondary Alveolar Bone Grafting
University Hospital, Montpellier·ClinicalTrials.govCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Alveolar Cleft
Study type
Observational
Sponsor & location
Primary sponsor
University Hospital, Montpellier
Location
Montpellier, France
Timeline & enrollment
Phase
N/A
Start date
Apr 01, 2021
End date
Jul 30, 2021
Enrollment
49 participants
Primary outcome

Kamperos's score

Summary

Study about the comparison of post-operative results of secondary alveolar grafts according
 to two age groups: early secondary (4 to 7 years) versus late secondary (8 to 11 years) using
 a recently proposed score based on post-operative 3D CT analysis.
 
 Comparison of the initial results of the graft in the two groups, with a reference 2D score
 and evaluation of the concordance between the results found with this score and those of the
 3D score.
 
 Finally, comparison of graft bone densities and nasal floor level (using 3D visualization) on
 post-operative TDMs in the 2 groups.
 
 The aim of this study is to determine the optimal age for grafting using three-dimensional CT
 assessment.

ICD-10 classifications
Cleft palateCleft palate, unspecifiedCleft soft palateOther branchial cleft malformationsCleft uvula
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04845308
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04845308 through Pure Global AI's free database. This phase not specified trial is sponsored by University Hospital, Montpellier and is currently Completed. The study focuses on Alveolar Cleft. Target enrollment is 49 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.